Hypertension in the postpartum woman: Clinical update for the hypertension specialist

Journal of Clinical Hypertension

Volumn 11, Issue 12, 2009, Pages 726-733

  Ghuman, Nimrta ^a   Rheiner, Jacqueline ^a   Tendler, Beatriz E ^a   White, William B ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CENTRAL NERVOUS SYSTEM AGENTS; DIHYDROPYRIDINE; DILTIAZEM; HYDRALAZINE; HYDROCHLOROTHIAZIDE; IBUPROFEN; LABETALOL; MAGNESIUM SULFATE; METHYLDOPA; METOCLOPRAMIDE; METOPROLOL TARTRATE; MICROSOME ANTIBODY; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; POTASSIUM; PROTEIN; THIAZIDE DIURETIC AGENT; THYROGLOBULIN ANTIBODY; URIC ACID; VERAPAMIL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; DRUG CONTRAINDICATION; DRUG MEGADOSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EDEMA; FATIGUE; FEMALE; FOLLOW UP; HEART PALPITATION; HOSPITAL DISCHARGE; HUMAN; HYPERTHYROIDISM; KIDNEY DISEASE; LACTATION; LOW DRUG DOSE; LUMBAR PUNCTURE; MATERNAL DISEASE; PAIN; PHOTOPHOBIA; POSTPARTUM HYPERTENSION; POSTPARTUM THYROIDITIS; POTASSIUM BLOOD LEVEL; PREECLAMPSIA; PRIMIGRAVIDA; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PUERPERIUM; REVIEW; SODIUM RESTRICTION; SYMPTOMATOLOGY; URIC ACID BLOOD LEVEL;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; DIURETICS; DOPAMINE ANTAGONISTS; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; MILK, HUMAN; PREGNANCY; PUERPERAL DISORDERS; RENIN-ANGIOTENSIN SYSTEM; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 70849102822     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2009.00186.x     Document Type: Review

References (24)

1. Diagnosis and Management of Preeclampsia and Eclampsia 2002, American College of Obstetricians and Gynecologist, Centers for Disease Control and Prevention, Washington DC, ACOG Practice Bulletin No. 33
2. Ojogwu LI, Ofili UG. Morbidity and mortality from postpartum hypertension in Nigerian women. Afr J Med Med Sci 1993, 22:11-16.
3. Van Oppen A, Stigter R, Bruinse H. Cardiac output in normal pregnancy: a critical review. Obstet Gynecol 1996, 87:310-331.
4. Sarafidis PA, Bakris GL. Resistant hypertension: an overview of evaluation and treatment. J Am Coll Cardiol 2008, 52:1749-1757.
5. White WB. Cardiovascular effects of the cyclooxygenase inhibitors. Hypertension 2007, 49:408-418.
6. Makris A, Thornton C, Hennessy A. Postpartum hypertension and nonsteroidal analgesia. Am J Obstet Gynecol 2004, 190:577-578.
7. Matthys LA, Coppage KH, Lambers DS. Delayed postpartum preeclampsia: an experience of 151 cases. Am J Obstet Gynecol 2004, 190:1464-1466.
8. Yancey LM, Withers E, Bakes K. Postpartum preeclampsia: emergency department presentation and management. J Emerg Med 2008, Sep 22. (epub ahead of print
9. Sibai BM. Diagnosis, prevention, and management of eclampsia. Obstet Gynecol 2005, 105:402-410.
10. Podymow T, August P. Hypertension in pregnancy. Adv Chronic Kidney Dis 2007, 14:178-190.
11. White WB, Andreoli JA. Painless postpartum thyroiditis seen initially as severe hypertension. Am J Obstet Gynecol 1984, 148:346-347.
12. Stagnaro-Green A. Postpartum thyroiditis. J Clin Endocrinol Metab 2002, 87:4042-4047.
13. Lindheimer MD, Taler SJ, Cunningham FG. Hypertension in pregnancy. J Am Soc Hypertens 2008, 2:484-494.
14. Rabasseda X. New Joint European Society of Hypertension/European Society of Cardiology guidelines for the management of arterial hypertension. Timely Top Med Cardiovasc Dis 2007, 11:E18.
15. Magee L, Sadeghi S. Prevention and treatment of postpartum hypertension. Cochrane Database Syst Rev 2005, (1). doi
16. Ferrazzani S, De Carolis S, Pomini F. The duration of hypertension in the puerperium of preeclamptic women; relationship with renal impairment and week of delivery. Am J Obstet Gynecol 1994, 171:506-512.
17. White WB. Management of hypertension during lactation. Hypertension 1984, 6:297-300.
18. Healy M. Suppressing lactation with oral diuretics. Lancet 1961, 1:13534.
19. Ghanem FA, Movahed A. Use of antihypertensive drugs during pregnancy and lactation. Cardiovasc Ther 2008, 26:38-49.
20. American Academy of Pediatrics: the transfer of drugs and other chemicals into human milk. Pediatrics 2001, 108:776-789. Committee on Drugs
21. Shannon ME, Malecha SE, Cha AJ. Calcium channel antagonists and lactation: an update. J Hum Lact 2000, 16:60-64.
22. Shannon ME, Malecha SE, Cha AJ. Angiotensin converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) and lactation: an update. J Hum Lact 2000, 16:152-155.
23. Cooper WO, Hernandez-Diaz S, Arbogast PG. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006, 354:2443-2451.
24. Liedholm H, Wahlin-Boll E, Hanson A. Transplacental passage and breast milk concentrations of hydralazine. Eur J Clin Pharmacol 1982, 21:417-419.